These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 10376414)
1. [Targeted and controlled release of drugs using magnetoliposomes]. Babincová M Ceska Slov Farm; 1999 Jan; 48(1):27-9. PubMed ID: 10376414 [TBL] [Abstract][Full Text] [Related]
2. Magnetoliposomes prepared by reverse-phase followed by sequential extrusion: characterization and possibilities in the treatment of inflammation. García-Jimeno S; Escribano E; Queralt J; Estelrich J Int J Pharm; 2011 Feb; 405(1-2):181-7. PubMed ID: 21129463 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of extruded magnetoliposomes. Sabaté R; Barnadas-Rodríguez R; Callejas-Fernández J; Hidalgo-Alvarez R; Estelrich J Int J Pharm; 2008 Jan; 347(1-2):156-62. PubMed ID: 17692483 [TBL] [Abstract][Full Text] [Related]
4. Characterization and cytotoxicity studies on liposome-hydrophobic magnetite hybrid colloids. Floris A; Sinico C; Fadda AM; Lai F; Marongiu F; Scano A; Pilloni M; Angius F; Vázquez-Vázquez C; Ennas G J Colloid Interface Sci; 2014 Jul; 425():118-27. PubMed ID: 24776672 [TBL] [Abstract][Full Text] [Related]
5. Principles of magnetodynamic chemotherapy. Babincová M; Leszczynska D; Sourivong P; Babinec P; Leszczynski J Med Hypotheses; 2004; 62(3):375-7. PubMed ID: 14975506 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of dextran magnetite-incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness. Viroonchatapan E; Ueno M; Sato H; Adachi I; Nagae H; Tazawa K; Horikoshi I Pharm Res; 1995 Aug; 12(8):1176-83. PubMed ID: 7494831 [TBL] [Abstract][Full Text] [Related]
7. Magnetoliposomes may be useful for elimination of HIV from infected individuals. Babincová M; Machová E Z Naturforsch C J Biosci; 1998; 53(9-10):935-6. PubMed ID: 9825547 [TBL] [Abstract][Full Text] [Related]
8. [Preparation of magnetoliposomes and its in vivo behavior on ICR mice]. Wu KS; Tang JT; Liu X; Zhang Q Yao Xue Xue Bao; 2004 Apr; 39(4):288-91. PubMed ID: 15303661 [TBL] [Abstract][Full Text] [Related]
9. Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia. Shinkai M; Suzuki M; Iijima S; Kobayashi T Biotechnol Appl Biochem; 1995 Apr; 21(2):125-37. PubMed ID: 7718156 [TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization of surfactant incorporating vesicles that incorporate colloidal magnetite. de Melo Barbosa R; Luna Finkler CL; Bentley MV; Santana MH J Liposome Res; 2013 Mar; 23(1):47-53. PubMed ID: 23363304 [TBL] [Abstract][Full Text] [Related]
11. Controlled Release of Doxorubicin from Magnetoliposomes Assisted by Low-Frequency Magnetic Field. Maron E; Krysinski P; Chudy M Chem Biodivers; 2023 Apr; 20(4):e202201079. PubMed ID: 36840686 [TBL] [Abstract][Full Text] [Related]
12. Microwave absorption by magnetite: a possible mechanism for coupling nonthermal levels of radiation to biological systems. Kirschvink JL Bioelectromagnetics; 1996; 17(3):187-94. PubMed ID: 8809358 [TBL] [Abstract][Full Text] [Related]
13. Hyperthermia and temperature-sensitive liposomes: selective delivery of drugs into the eye. Khoobehi B; Peyman GA; Niesman MR; Oncel M Jpn J Ophthalmol; 1989; 33(4):405-12. PubMed ID: 2625775 [TBL] [Abstract][Full Text] [Related]
14. Controllable release from high-transition temperature magnetoliposomes by low-level magnetic stimulation. Spera R; Apollonio F; Liberti M; Paffi A; Merla C; Pinto R; Petralito S Colloids Surf B Biointerfaces; 2015 Jul; 131():136-40. PubMed ID: 26042528 [TBL] [Abstract][Full Text] [Related]
15. Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Fortin-Ripoche JP; Martina MS; Gazeau F; Ménager C; Wilhelm C; Bacri JC; Lesieur S; Clément O Radiology; 2006 May; 239(2):415-24. PubMed ID: 16549622 [TBL] [Abstract][Full Text] [Related]
17. Controlled release from magnetoliposomes aqueous suspensions exposed to a low intensity magnetic field. Spera R; Petralito S; Liberti M; Merla C; d'Inzeo G; Pinto R; Apollonio F Bioelectromagnetics; 2014 May; 35(4):309-12. PubMed ID: 24482311 [TBL] [Abstract][Full Text] [Related]
18. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Ito A; Kuga Y; Honda H; Kikkawa H; Horiuchi A; Watanabe Y; Kobayashi T Cancer Lett; 2004 Aug; 212(2):167-75. PubMed ID: 15279897 [TBL] [Abstract][Full Text] [Related]
19. Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. Qiu D; An X Colloids Surf B Biointerfaces; 2013 Apr; 104():326-9. PubMed ID: 23290769 [TBL] [Abstract][Full Text] [Related]
20. Biotinylated Stealth magnetoliposomes. Hodenius M; De Cuyper M; Desender L; Müller-Schulte D; Steigel A; Lueken H Chem Phys Lipids; 2002 Dec; 120(1-2):75-85. PubMed ID: 12426077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]